Matthew Pratt Whalen - Aug 8, 2024 Form 3 Insider Report for Telomir Pharmaceuticals, Inc. (TELO)

Role
Director
Signature
/s/ Matthew Pratt Whalen
Stock symbol
TELO
Transactions as of
Aug 8, 2024
Transactions value $
$0
Form type
3
Date filed
8/15/2024, 11:17 AM
Next filing
Aug 29, 2024

No securities are beneficially owned.